Terminated NA INTERVENTIONAL 4-arm NCT03465579

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. (BIOPSTAGE)

Multi-cohort Investigational Study to Evaluate the Impact of Pelvic Mp-3TMRI and Whole-body 68Ga-PSMA PET/CT for Diagnosis of Clinically-significant Prostate Cancer and Pre-surgical Staging.

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Conditions 68Ga-PSMA PET/CT Guided Prostate Biopsy Diagnosis Mp-3TMRI Guided Prostate Biopsy Prostate Cancer TNM Staging

Interventions 68Ga-PSMA PET/CT pelvic MRI

Updated 11 times since 2018 Last updated: Jan 28, 2025 Started: May 23, 2018 Primary completion: Sep 3, 2024 Completion: Sep 3, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Patients in cohort 1 continued for prolonged periods given the difficulties encountered in the COVID period and to date in this setting evidence has already developed that reduces the the innovativeness of the project.

Other terminated trials from Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

See all terminations from Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

This NA trial investigates 68Ga-PSMA PET/CT Guided Prostate Biopsy and Diagnosis and is currently terminated or withdrawn. Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

11 versions recorded

Apr 2025 — Present [monthly]

Terminated NA
Feb 2025 — Apr 2025 [monthly]

Terminated NA

Status: Recruiting → Terminated
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jul 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting

▶ Show 6 earlier versions

Mar 2023 — Jul 2023 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Mar 2021 — Mar 2023 [monthly]

Recruiting NA
Jan 2021 — Mar 2021 [monthly]

Recruiting NA
May 2020 — Jan 2021 [monthly]

Recruiting NA
Dec 2018 — May 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Mar 2018 — Dec 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Data source: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Forlì, Italy
• Meldola, Italy